Strides Pharma Science Limited (BOM:532531)

Strides Pharma Science Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 21, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	62,767	72,114	25,858	31,121	75,754	28,854
Market Cap Growth	1.87%	178.88%	-16.91%	-58.92%	162.55%	-31.79%
Enterprise Value	82,818	96,197	55,452	54,820	95,516	45,851
Last Close Price	680.95	327.77	119.44	144.65	351.37	133.56
PE Ratio	1.78	-	-	-	28.22	79.29
PS Ratio	1.37	1.78	0.70	1.01	2.29	1.05
PB Ratio	2.83	3.48	1.19	1.31	2.69	1.11
P/TBV Ratio	5.50	6.75	2.28	2.49	4.52	1.86
P/FCF Ratio	-	12.37	-	-	41.18	52.67
P/OCF Ratio	-	10.29	58.23	-	15.74	14.09
EV/Sales Ratio	1.81	2.38	1.50	1.79	2.88	1.67
EV/EBITDA Ratio	10.58	13.92	16.30	-	16.07	8.69
EV/EBIT Ratio	14.14	18.69	38.52	-	22.31	12.27
EV/FCF Ratio	-	16.50	-	-	51.92	83.69
Debt / Equity Ratio	1.04	1.22	1.39	1.27	0.83	0.86
Debt / EBITDA Ratio	2.45	3.46	8.10	-	3.81	4.08
Debt / FCF Ratio	-	4.32	-	-	12.77	40.79
Asset Turnover	-	0.65	0.54	0.44	0.50	0.39
Inventory Turnover	-	1.59	1.52	1.36	1.43	1.45
Quick Ratio	-	0.55	0.59	0.58	0.52	0.52
Current Ratio	-	1.03	1.09	0.99	1.03	0.93
Return on Equity (ROE)	-	-7.00%	-10.13%	-18.25%	9.01%	1.61%
Return on Assets (ROA)	-	5.16%	1.32%	-2.12%	4.06%	3.31%
Return on Capital (ROIC)	9.99%	6.57%	1.70%	-2.81%	5.36%	4.29%
Return on Capital Employed (ROCE)	-	17.40%	3.90%	-	10.00%	10.40%
Earnings Yield	56.23%	-0.98%	-7.84%	-14.79%	3.54%	1.26%
FCF Yield	-	8.08%	-1.95%	-12.89%	2.43%	1.90%
Dividend Yield	132.84%	0.76%	1.26%	-	0.71%	1.50%
Payout Ratio	-	-	-	-	6.67%	84.58%
Buyback Yield / Dilution	-1.52%	-1.02%	-0.37%	-0.04%	-0.14%	-0.01%
Total Shareholder Return	131.32%	-0.26%	0.89%	-0.04%	0.57%	1.49%

Updated Jan 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.